Both CD8+ and CD4+ T regulatory cells are associated with poor survival in colorectal cancer

Read full text
Authors: Zhiyuan Cheng, Anthony Gyening-Yeboah, Wakkas Fadhil, Abhik Mukherjee, Ahmed Barakat, Anna A. Malecka, Andrew M. Jackson, Mohammad Ilyas, Ian Spendlove, Judith M. Ramage
Cited by: 0
References: 41

Abstract

Abstract Previous studies in colorectal cancer have linked high levels of FoxP3+ regulatory T-cells (Treg) (CRC) to a favourable prognosis. However, this contradicts the well-established immunosuppressive function of Treg. We resolved this conundrum using multiplex immunohistochemistry to characterise Foxp3 + and IL-10 + Treg in 1000 consecutively recruited patients’ tumours. Although Foxp3 + cells were associated with improved outcomes, this effect was confounded by high numbers of CD8+ effector T-cells (Teff). In contrast, a high percentage of CD8 + Treg to CD8 + Teff cells correlated with poor survival. Although the total CD4 + T-cell count was not prognostic, CD4+Teff were linked to improved outcomes, suggesting that the Treg fraction within the population may mask beneficial immune responses. Spatial proximity (

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology Immune Cell Function and Interaction

Publication details

Journal / source
npj Precision Oncology
Publisher
Springer Science and Business Media LLC
Publication date
20 August 2026
Language
EN